Document
type: Class

16319852
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events : a combined analysis of 3 pivotal, randomised, phase 3 trials

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events : a combined analysis of 3 pivotal, randomised, phase 3 trials
language: English
most specific type: Academic Article
type: Thing
type: Generically Dependent Continuant
type: Academic Article
type: Document
type: Information Content Entity
related by: 16319852
type: Article
type: Entity
type: Continuant

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Article
type: Class

English
type: Language

Information Content Entity
type: Class

individual
rights: termsOfUse
date: 2026-08-04T05:08:30
publisher: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events : a combined analysis of 3 pivotal, randomised, phase 3 trials
type: Document
label: RDF description of Superiority of denosumab to zoledronic acid for prevention of skeletal-related events : a combined analysis of 3 pivotal, randomised, phase 3 trials - http://irises.unimi.it/resource/item/363487